Steven Arnold
Acute Care · McComb, MSNPI 1629243530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Abbott at 24.0% of the total.
Across 131 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$533
- Novartis$425
- Boston Scientific$233
- Abiomed$152
- Merck$138
- E.r. Squibb & Sons, L.L.C.$106
- plus $630 from 18 others
What the payments were for
- Food & beverage$2,19699%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 31 | $533 |
| Novartis | 30 | $425 |
| Boston Scientific | 11 | $233 |
| Abiomed | 7 | $152 |
| Merck | 8 | $138 |
| E.r. Squibb & Sons, L.L.C. | 7 | $106 |
| Johnson & Johnson | 5 | $76 |
| Biosense Webster, Inc. | 3 | $74 |
| Boehringer Ingelheim | 4 | $73 |
| Amgen | 4 | $54 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| AstraZeneca | 4 | $51 |
| Scpharmaceuticals Inc. | 2 | $45 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $42 |
| Bayer | 1 | $28 |
| Astellas Pharma US Inc | 1 | $24 |
| Philips North America LLC | 1 | $21 |
| Chiesi USA, Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Pfizer | 1 | $12 |
| Lexicon Pharmaceuticals, Inc. | 1 | $8 |
How this compares
$2,217 in reported general payments places this provider in the 75th percentile of 223 acute care providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 60 | $1,691 |
| Colchicine | 35 | $395 |
| Pantoprazole Sodium | 50 | $287 |
| Metoprolol Succinate | 12 | $87 |
| Furosemide | 24 | $56 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other acute care in McComb
- Marlee BootyMcComb$8K
- Gary BoggsMcComb$3K
- Christopher BellTupelo$348K
- Kathleen ArnoldOcean Springs$217K
- Gavin GistOxford$42K
- Jamie DamicoOcean Springs$17K
- Dylan BoydHattiesburg$15K
- Melinda ClarkStarkville$14K
- Michelle TaylorGulfport$13K
- Aaron KatzenmeyerMadison$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.